Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, LAB Research, Cedra and InVentiv Health.
Eli Lilly, Merck & Co and Pfizer are combining resources to form the Asian Cancer Research Group (ACRG), a non-profit company which aims to accelerate research into lung and gastric cancers in Asia.
Helvoet Pharma is to build a €14m ($19m) rubber parenteral packaging component facility in India to meet rising demand for products made to international quality standards.
Aesica is looking to acquire manufacturing assets in the US to expand its client base in the country and continue the growth it has maintained throughout the economic downturn.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Noven, Inspire, AP Pharma and Tarsa Therapeutics.
US Pharma firms can benefit from the sourcing, storage and distribution efficiencies offered by comparator drug sourcing and distribution specialist Pharmarama says managing director Rosemary Bensley.
Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.
TGen Drug Development (TD2) and Rondaxe Enterprises have entered into a strategic alliance to broaden their oncology service offerings and help link chemistry to translational medicine.
There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.
West Pharmaceutical Services reported strong fourth quarter results, underpinned by demand for H1N1 components, but still posted a dip in operating income for its 2009 financial year.
AMRI has acquired Wales-based Excelsyn for $19m (€14m) to help it target the European market and improve its ability to offer low cost services.
RecipharmCobra Biologics (RCB) launched today as a specialist biologics contract development and manufacturing organization (CDMO).
The Chinese API sector shrank last year after a number of high profile quality problems hit demand from Western markets, according to new analysis by outsourcing consultant JZ Med.
Contract API maker Ampac Fine chemicals (AFC) has had a busy 24-hours, entering the Japanese market through a deal with Inabata and forging an alliance with Codexis on biocatalyst technology.
US group Aptuit has bolstered its chemistry offering with a new solid state chemistry screen that it says will enable better decisions during drug formulation development and process scale-up.